Upper Respiratory Viral Infections in Patients with Haematological Malignancies after Allogeneic Haematopoietic Stem Cell Transplantation: A Retrospective Study

Abstract

Background

Community respiratory viruses (CRVs) are associated with upper respiratory viral infections (URI), pneumonia or life-threatening respiratory disease in patients with allogeneic haematopoietic stem cell transplantation (allo-HSCT). Our aim is to demonstrate our URI experience related to CRVs after allo-HSCT.

Methods

From January 2013 to November 2015, 39 post allo-HSCT patients with acute URI symptoms were included in the study. We evaluated CRVs by multiplex PCR from nasopharyngeal wash and throat swabs.

Results

The median age of the patients was 39 (range 20–67 years). A total of 25 patients (64%) had viral panel positivity at a median 140 days post-transplant (range 3–617 days). The most common agents detected were respiratory syncytial virus (32%) and parainfluenza (32%). The patients with viral panel positivity had significantly lower lymphocyte count (1.05x10⁹/l versus 3.09x10⁹/l; P=0.013). During follow-up, 20 patients (80%) were diagnosed with pneumonia. Patients with concurrent bacterial or fungal infections were more likely to have pneumonia (100% versus 68%; P=0.023). 10 patients (40%) died due to pneumonia and related complications. Lower lymphocyte counts and higher C-reactive protein levels at the time of viral panel positivity were risk factors for mortality (1.5x10⁹/l versus 0.39x10⁹/l, P=0.007; 74.2 versus 199.7, P=0.006).

Conclusions

The viral panel was positive in 64% of patients with acute URI symptoms. Lower lymphocyte count was detected in CRV-positive patients. The onset of concomitant bacterial or fungal infections increased the risk of lower respiratory infection disease. Indeed, prospective studies should be designed for risks and outcomes of CRVs in allo-HSCT recipients.

References

Ghosh

, Champlin

, Couch

Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients.

Clin Infect Dis 1999; 29: 528–532.

Ison

M.G.

, Hayden

F.G.

, Kaiser

, Corey

, Boeckh

Rhinovirus infections in hematopoietic stem cell transplant recipients with pneumonia.

Clin Infect Dis 2003; 36: 1139–1143.

Chakrabarti

, Osman

, Collingham

K.E.

, Fegan

C.D.

, Milligan

D.W.

Enterovirus infections following T-cell depleted allogeneic transplants in adults.

Bone Marrow Transplant 2004; 33: 425–430.

González

, Martino

, Badell

Pulmonary enterovirus infections in stem cell transplant recipients.

Bone Marrow Transplant 1999; 23: 511–513.

Chemaly

R.F.

, Ghosh

, Bodey

G.P.

Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients. A retrospective study at a major cancer center.

Medicine (Baltimore) 2006; 85: 278–287.

Green

M.L.

Viral pneumonia in patients with hematopoietic cell transplantation and hematologic malignancies.

Clin Chest Med 2017; 38: 295–305.

Hassan

I.A.

, Chopra

, Swindell

, Mutton

J.M.

Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie Hospital experience.

Bone Marrow Transplant 2003; 32: 73–77.

Ljungman

, Ward

K.N.

, Crooks

B.N.

Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

Bone Marrow Transplant 2001; 28: 479–484.

Machado

C.M.

, Vilas Boas

L.S.

, Mendes

A.V.A.

Low mortality rates related to respiratory virus infections after bone marrow transplantation.

Bone Marrow Transplant 2003; 31: 695–700.

10.

Nichols

W.G.

, Gooley

, Boeckh

Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center Experience.

Biol Blood Marrow Transplant 2001; 7 Suppl: 11S–15S.

11.

Chien

J.W.

, Martin

P.J.

, Gooley

T.A.

Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation.

Am J Respir Crit Care Med 2003; 168: 208–214.

12.

Erard

, Chien

J.W.

, Kim

H.W.

Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses.

J Infect Dis 2006; 193: 1619–1625.

13.

Champlin

R.E.

, Whimbey

Community respiratory virus infections in bone marrow transplant recipients. The M. D. Anderson Cancer Center experience.

Biol Blood Marrow Transplant 2001; 7 Suppl: 8S–10S.

14.

Ebbert

J.O.

, Limper

A.H.

Respiratory syncytial virus pneumonitis in immunocompromised adults: clinical features and outcome.

Respiration 2005; 72: 263–269.

15.

Ghosh

, Champlin

R.E.

, Englund

Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin.

Bone Marrow Transplant 2000; 25: 751–755.

16.

Martino

, Porras

R.P.

, Rabella

Prospective study of the incidence, clinical features and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies.

Biol Blood Marrow Transplant 2005; 11: 781–796.

17.

Dignan

F.L.

, Clark

, Aitken

BCSH/BSBMT/UK clinical virology network guideline:diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation.

Br J Haematol 2016; 173: 380–393.

18.

Englund

J.A.

, Piedra

P.A.

, Jewell

, Patel

, Baxter

B.B.

, Whimbey

Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults.

J Clin Microbiol 1996; 34: 1649–1653.

19.

Coiras

M.T.

, Perez-Brena

, Garcia

M.L.

, Casas

Simultaneous detection of influenza A, B, and C viruses, respiratory syncytial virus, and adenoviruses in clinical samples by multiplex reverse transcription nested-PCR assay.

J Med Virol 2003; 69: 132–144.

20.

Falsey

A.R.

, McCann

R.M.

, Hall

, Criddle

M.M.

Evaluation of four methods for the diagnosis of RSV infections in immunocompromised adults.

J Am Geriatr Soc 1996; 44: 71–73.

21.

Fan

, Henrickson

K.J.

, Savatski

L.L.

Rapid simultaneous diagnosis of infections with RSV viruses A and B, influenza A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse transcription-polymerase chain reaction-enzyme hybridization assay (Hexaplex).

Clin Infect Dis 1998; 26: 1397–1402.

22.

van Elden

L.J.

, van Kraaij

M.G.

, Nijhuis

Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with hematological cancer and pneumonia.

Clin Infect Dis 2002; 34: 177–183.

23.

Hirsch

H.H.

, Martino

, Ward

K.N.

, Boeckh

, Einsele

, Ljungman

Fourth European Conference on Infections in Leukeaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus and coronovirus.

Clin Infec Dis 2013; 56: 258–266.

24.

Milano

, Campbell

A.P.

, Guthrie

K.A.

Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients.

Blood 2010; 115: 2088–2094.

25.

Turner

R.B.

Upper respiratory tract infections section B. In: Mandell , Douglas , Bennett , ed. Principles and practice of infectious diseases. 7th ed. Philadelphia: Elsevier 2010; pp. 809–813.

26.

Campbell

A.P.

, Chien

J.W.

, Kuypers

Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT.

J Infect Dis 2010; 201: 1404–1413.

27.

Robin

, Marque-Juillet

, Scieux

Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome.

Haematologica 2007; 92: 1254–1257.

28.

Ljungman

, de la Camara

, Perez-Bercoff

Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients.

Haematologica 2011; 96: 1231–1235.

29.

Chemaly

R.F.

, Shah

D.P.

, Boeckh

M.J.

Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies.

Clin Infect Dis 2014; 59 Suppl 2: S344–S351.

30.

Waghmare

, Englung

J.A.

, Boeckh

How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation.

Blood 2016; 127: 2682–2692.

31.

La Rosa

A.M.

, Champlin

R.E.

, Mirza

Adenovirus infections in adult recipients of blood and marrow transplants.

Clin Infect Dis 2001; 32: 871–876.

32.

Marcolini

J.A.

, Malik

, Suki

, Whimbey

, Bodey

G.P.

Respiratory disease due to parainfluenza virus in adult leukemia patients.

Eur J Clin Microbiol Infect Dis 2003; 22: 79–84.

33.

Whimbey

, Ghosh

Respiratory syncytial virus infections in immunocompromised adults.

Curr Clin Top Infect Dis 2000; 20: 232–255.